In an interim analysis of this phase 3 trial, the addition of pembrolizumab to chemotherapy resulted in longer progression-free survival than chemotherapy alone among patients with advanced ...

The announcement, made by the WHO Director-General Dr. Tedros Adhanom Ghebreyesus, celebrates the Maldives’ extraordinary ...